Target intelligence / Profile preview

Sialic acid and heparan sulfate glycans (SA/HS glycans)

Target
SA/HS glycans
Molecular classification
Glycan, Carbohydrate, Glycosaminoglycan, Receptor
01

Overview

Sialic acid-containing glycans and heparan sulfate glycans are complex carbohydrate structures found on the surfaces of both host cells and various microorganisms. These molecules serve as critical attachment factors and coreceptors for a wide range of pathogens, including influenza viruses, herpesviruses, and coronaviruses, which utilize them to facilitate initial docking and subsequent entry into host cells (Varki, A., 2008, Nature; Lopes, C.C. et al., 2006, Glycobiology). In addition to their role in pathogenesis, these glycans are essential for normal physiological processes such as cell-cell communication, signal transduction, and the maintenance of the extracellular matrix (Bishop, J.R. et al., 2007, Nature). Therapeutic interventions targeting these glycans typically employ decoy mimetics that competitively bind to pathogen surface proteins or enzymes like sialidases that remove the glycan receptors from the host cell surface (Triana-Baltzer, G.B. et al., 2009, PLoS ONE). Such strategies offer the potential for broad-spectrum antimicrobial activity by targeting conserved entry mechanisms (Cagno, V. et al., 2018, Nature Materials). However, the ubiquity of these glycans presents challenges, as therapeutic agents must avoid interfering with vital host functions like blood coagulation and immune regulation.

Other names
Microbial and host cell surface sialic acid-containing and heparan sulfate glycansSialoglycansHeparan sulfate proteoglycansHSPGsCell surface carbohydratesGlycosaminoglycansPathogen attachment factors
02

Mechanism of action

Competitive inhibition of pathogen attachment to host cells via glycan mimetics or enzymatic depletion of host cell surface glycan receptors.

03

Biological functions

Cell adhesionPathogen attachmentSignal transductionExtracellular matrix organizationImmune response
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

Anticoagulant effectsDisruption of endogenous growth factor signalingPotential for mucosal inflammation or dysbiosis
06

Interacting drugs

DAS181

7 more in the full profile.

07

Biomarkers

Sialic acid densityHeparan sulfate sulfation patternsViral load reduction

Beyond the preview

Go deeper on Sialic acid and heparan sulfate glycans (SA/HS glycans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid and heparan sulfate glycans (SA/HS glycans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call